Beta-blocker use and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia [0.03%]
Johanna Werk,David Baden,Inna Shaforostova et al.
Johanna Werk et al.
Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for patients with acute myeloid leukemia (AML) through an immune-mediated graft-versus-leukemia effect, but relapse is common. Studies in solid tumors have shown that adr...
Risk factors for leukemic transformation in myeloproliferative neoplasms and prognostic factors in secondary acute myeloid leukemia: an exploratory analysis of the SEER database [0.03%]
Shuainan Wang,Haoyu Zang,Wenjing Du et al.
Shuainan Wang et al.
To identify risk factors for secondary acute myeloid leukemia (sAML) transformation in myeloproliferative neoplasms (MPN), determine prognostic factors, and construct a reliable prognostic risk model, this study performed a retrospective an...
Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups [0.03%]
Cristina Rivera-Pérez,Mireia Morgades,Anna Alonso-Saladrigues et al.
Cristina Rivera-Pérez et al.
Patients with relapsed/refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) have very poor prognosis. CAR T-cell therapy is being explored in these patients with encouraging results. Specifically, CD1a-directed CAR T-cells are being e...
Outcomes of hematopoietic stem cell transplantation in adult sickle cell disease patients: A Single-Center experience from India [0.03%]
Anusha Swaminathan,Nikhil M Kumar,Shrinidhi Nathany et al.
Anusha Swaminathan et al.
Sickle cell disease (SCD) in adults remains a significant clinical challenge, with limited curative options and high morbidity and mortality. Hematopoietic stem cell transplantation (HSCT) offers a potential cure, yet data on its feasibilit...
Evani Patel,Ajit Singh,Douglas Beach et al.
Evani Patel et al.
Occult hematologic malignancies can initially present with cutaneous manifestations. We describe a 53-year-old woman with chronic hepatitis C and intravenous drug use presenting with a painful, progressive leg rash and worsening bicytopenia...
FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification [0.03%]
Bo Lu,Ting Bin,Xue-Fei Deng et al.
Bo Lu et al.
Background: Fat Mass and Obesity-Associated (FTO) is linked to multiple myeloma (MM) progression, but its action mechanisms are poorly understood. Methods...
Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients [0.03%]
Lingli Wang,Jinping Pi,Xiaohui He et al.
Lingli Wang et al.
Classical Hodgkin lymphoma (cHL) has excellent survival outcomes, but real-world data from large-scale cohorts in China remain limited. This multicenter study characterized the clinical profile of a large Chinese cHL cohort to evaluate the ...
Predictors of 30-day readmissions post-CAR-T in patients with relapsed/refractory multiple myeloma using the United States nationwide readmission database [0.03%]
Raj Shah,Nikhil Vojjala,Tiewei Cheng et al.
Raj Shah et al.
B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy has changed the therapeutic landscape of relapsed/refractory multiple myeloma (RRMM). Despite the efficacy, these products have been associated with ...
The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions [0.03%]
Shuangzhu Liu,Biqi Zhou,Chongsheng Qian et al.
Shuangzhu Liu et al.
To investigate the clinical characteristics and prognosis of acute B-cell lymphoblastic leukemia (B-ALL) patients with MEF2D fusions. We retrospectively analyzed 15 newly diagnosed MEF2D-positive B-ALL patients admitted to The First Affilia...
Adiponectin levels during steady state and vaso-occlusive crisis in Nigerian children with sickle cell anaemia [0.03%]
Arinze Ejike Ulasi,Chisom Adaobi Nri-Ezedi,Henry Chima Okpara et al.
Arinze Ejike Ulasi et al.
Sickle cell anaemia (SCA) is a chronic inflammatory hemoglobinopathy marked by recurrent vaso-occlusive crises (VOC) and end-organ damage. Adiponectin, an adipokine with anti-inflammatory and insulin-sensitizing properties, is well-studied ...